Detección e identificación de Streptococcus agalactiae en gestantes: aspectos relevantes y revisión narrativa de la literatura

Detection and identification of Streptococcus agalactiae in pregnant women: Relevant aspects and a narrative literature review

Publicado 2025-09-03


https://doi.org/10.30554/archmed.25.2.5305.2025
Abrir | Descargar
PDF FLIP
Número
Vol. 25 Núm. 2 (2025): Revista Archivos de Medicina (Manizales)
Sección
Artículos de Revisión
Cómo citar
Crespo Ortiz, M. del P., & Nieva Posso, D. A. . (2025). Detección e identificación de Streptococcus agalactiae en gestantes: aspectos relevantes y revisión narrativa de la literatura. Archivos De Medicina, 25(2). https://doi.org/10.30554/archmed.25.2.5305.2025
Descargar cita
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.25.2.5305.2025
Dimensions
PlumX

Cómo citar

Crespo Ortiz, M. del P., & Nieva Posso, D. A. . (2025). Detección e identificación de Streptococcus agalactiae en gestantes: aspectos relevantes y revisión narrativa de la literatura. Archivos De Medicina, 25(2). https://doi.org/10.30554/archmed.25.2.5305.2025

Descargar cita

Licencia
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Maria del Pilar Crespo Ortiz
Universidad del Valle
https://orcid.org/0000-0003-2160-5167 ORCID
Daniel Andres Nieva Posso
Universidad del Valle
https://orcid.org/0000-0003-1193-0732 ORCID
Mostrar biografía de los autores

Maria del Pilar Crespo Ortiz,

Bacterióloga y Laboratorista clínica, MSc, PhD, Profesora titular. Grupo de Investigación en Microbiología y Enfermedades Infecciosas. Departamento de Microbiología. Universidad del Valle

Daniel Andres Nieva Posso,

Estudiante de Medicina/ Bacteriologo y Lab Clinico . Universidad del Valle

El Streptococcus agalactiae o Streptococcus del grupo B (SGB) es un patógeno relevante en salud materno-fetal y mundialmente es uno de los agentes etiológicos de sepsis neonatal temprana de alta letalidad y sepsis neonatal tardía causante de secuelas neurológicas permanentes y discapacidad infantil. La colonización materna es la principal fuente de transmisión de la sepsis temprana, la cual puede prevenirse mediante la profilaxis materna intraparto. El tamizaje prenatal mediante cultivo vagino-rectal constituye la principal herramienta para la detección de las gestantes colonizadas y en riesgo.  Objetivo: Esta revisión pretende brindar información actualizada sobre la carga de la infección por SGB y sus efectos en gestantes y neonatos enfocándose en el proceso óptimo de detección e identificación de la bacteria, así como las alternativas de diagnóstico molecular. Lo anterior con el fin de mejorar el limitado control de la infección debido a la falta de comprensión de estos aspectos. Metodología: Para la revisión del tema se realizó una búsqueda de la literatura en 4 bases de datos incluyendo estudios de la última década (hasta 2023). Se seleccionaron 82 artículos que cumplieron con los criterios para la revisión narrativa, la cual se realizó en concordancia con la guía SANRA. Resultados: Se describen aspectos microbiológicos, epidemiológicos y particularmente se discuten las limitaciones del cultivo vagino-rectal prenatal y los retos para la detección e identificación de la bacteria considerando la utilización de pruebas moleculares de punta. Conclusiones: El rendimiento del cultivo o estándar de oro es variable, lo cual disminuye su sensibilidad y poder diagnóstico. En esta revisión se hace evidente la alta sensibilidad y especificidad de las pruebas moleculares lo que hace imperativo incluir estas pruebas complementarias en la detección antenatal de la bacteria permitiendo la aplicación efectiva de la terapia intraparto y la prevención de la infección neonatal.

Visitas del artículo 83 | Visitas PDF 35

Descargas

Los datos de descarga todavía no están disponibles.
  1. 1. Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Braunstein M and Rood JI, editors. Gram-Positive Pathogens. Washington, DC, USA: ASM Press; 2019. p.228–238. doi: https://doi.org/10.1128/9781683670131.ch14
  2. 2. Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A, Seedat F, et al. Group B Streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022; 10(6):e807–19. doi: https://doi: 10.1016/S2214-109X(22)00093-6.
  3. 3. Stephens K, Charnock-Jones DS, Smith GCS. Group B Streptococcus and the risk of perinatal morbidity and mortality following term labor. Am J Obstet Gynecol. 2023; 228(5):S1305–12. doi: https://doi.org/10.1016/j.ajog.2022.07.051
  4. 4. Gizachew M, Tiruneh M, Moges F, Adefris M, Tigabu Z, Tessema B. Proportion of Streptococcus agalactiae vertical transmission and associated risk factors among Ethiopian mother-newborn dyads, Northwest Ethiopia. Sci Rep. 2020; 10(1):1–8. doi: https://doi.org/10.1038/s41598-020-60447-y
  5. 5. Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. Infant Group B Streptococcal Disease incidence and serotypes worldwide: Systematic review and meta-analyses. Clin Infect Dis. 2017; 65(S2): S60-S72. doi: https://doi.org/10.1093/cid/cix656
  6. 6. Filkins L, Hauser J, Robinson-Dunn B, Tibbetts R, Boyanton B, Revell P. Published 10 March 2020. Updated 23 July 2021. Guidelines for the Detection and Identification of Group B Streptococcus. American Society for Microbiology. Available in https://asm.org/Guideline/Guidelines-for-the-Detection-and-Identification-of.
  7. 7. da Rocha JZ, Feltraco J, Radin V, Gonçalves CV, da Silva PEA, von Groll A. Streptococcus agalactiae colonization and screening approach in high-risk pregnant women in southern Brazil. J Infect Dev Ctries. 2020; 14(4):332–40. doi: https://doi.org/10.3855/jidc.12025
  8. 8. Walker KF, Plumb J, Gray J, Thornton JG, Avery AJ, Daniels JP. Should all pregnant women be offered testing for group B Streptococcus? The BMJ. 2021; 373:1–10. doi: https://doi.org/10.1136/bmj.n882
  9. 9. World Health Organization. Group B Streptococcus vaccine: full value of vaccine assessment. 2021. 19–32 p. https://www.who.int/publications/i/item/9789240037526
  10. 10. Costa SC, Machado AP, Teixeira C, Cerqueira L, Rodrigues T, Ribeiro M, et al. Group B Streptococcus rectovaginal colonization screening on term pregnancies: ¿culture or polymerase chain reaction? J Matern Fetal Neonatal Med. 2023; 36(2). doi:https://doi.org/10.1080/14767058.2023.2262078.
  11. 11. Picchiassi E, Coata G, Babucci G, Giardina I, Summa V, Tarquini F, et al. Intrapartum test for detection of Group B Streptococcus colonization during labor. J Matern Fetal Neonatal Med. 2018; 31(24):3293–300. doi: https://doi.org/10.1080/14767058.2017.1369041
  12. 12. Hayes K, O’Halloran F, Cotter L. A review of antibiotic resistance in Group B Streptococcus: the story so far. Crit Rev Microbiol. 2020; 46(3):253–69. doi: https://doi.org/10.1080/1040841X.2020.1758626.
  13. 13. HogenEsch E, De Mucio B, Haddad LB, Vilajeliu A, Ropero AM, Yildirim I, et al. Differences in maternal group B Streptococcus screening rates in Latin American countries. Vaccine. 2021; 39: B3–11. doi: https://doi.org/10.1016/j.vaccine.2020.10.082.
  14. 14. Centro Nacional de Investigación en Evidencia y Tecnología en Salud. Guía de Práctica Clínica para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto o puerperio. Guías de Práctica Clínica. 2013. 1–84 p. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/G.Corta.Embarazo.y.parto.Prof.Salud.2013%20(1).pdf
  15. 15. Ospino-Muñoz AM, Bonza-González EA, Arévalo-Mojica CD, Rubio-Romero JA. Adherence to recommendations for preventing early neonatal sepsis associated with Streptococcus agalactiae colonization in a referral center in Bogotá, Colombia, 2019. Rev Colomb Obstet Ginecol. 2022; 73(3):175–83. doi: https://doi.org/10.18597/RCOG.3917.
  16. 16. Hernandez DR, Wolk DM, Walker KL, Young S, Dunn R, Dunbar SA, et al. Multicenter diagnostic accuracy evaluation of the luminex aries real-time PCR assay for group B Streptococcus detection in LIM broth-enriched samples. J Clin Microbiol. 2018; 56(8):1–9. doi: https://doi.org/10.1128/JCM.01768-17.
  17. 17. Di Renzo GC, Melin P, Berardi A, Blennow M, Carbonell-Estrany X, Donzelli GP, et al. Intrapartum GBS screening and antibiotic prophylaxis: A European consensus conference. J Matern Fetal Neonatal Med. 2015; 28(7):766–82. doi: https://doi.org/10.3109/14767058.2014.934804.
  18. 18. Shin JH, Pride DT. Comparison of three nucleic acid amplification tests and culture for detection of group B Streptococcus from enrichment broth. J Clin Microbiol. 2019; 57(6):1–9. doi: https://doi.org/10.1128/JCM.01958-18.
  19. 19. Rothen J, Sapugahawatte DN, Li C, Lo N, Vogel G, Foucault F, et al. A simple, rapid typing method for Streptococcus agalactiae based on ribosomal subunit proteins by MALDI-TOF MS. Sci Rep. 2020; 10(1):1–8. doi: https://doi.org/10.1038/s41598-020-65707-5.
  20. 20. Baethge C, Goldbeck-Wood S, Mertens S. SANRA una escala para la evaluación de la calidad de los artículos de revisión narrativa. [SANRA—a scale for the quality assessment of narrative review articles]. Res Integr Peer Rev 2019; 4: 2–8. https://doi.org/10.1186/s41073-019-0064-8
  21. 21. Sahuquillo-Arce JM, Hernández-Cabezas A, Castaño-Aroca MJ, Chouman-Arcas R, Díaz-Aguirre E, Acosta-Boga B, et al. Streptococcus agalactiae in childbearing age immigrant women in Comunitat Valenciana (Spain). Sci Rep. 2020; 10(1):1–8. doi: https://doi.org/10.1038/s41598-020-66811-2.
  22. 22. Bobadilla FJ, Novosak MG, Cortese IJ, Delgado OD, Laczeski ME. Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35–37 weeks of gestation. BMC Infect Dis. 2021; 21(1):1–11. doi: https://doi.org/10.1186/s12879-020-05603-5.
  23. 23. Del Carmen Palacios-Saucedo G, Rivera-Morales LG, Vazquez-Guillen JM, Caballero-Trejo A, Mellado-Garcia MC, Flores-Flores AS, et al. Genomic analysis of virulence factors and antimicrobial resistance of group B Streptococcus isolated from pregnant women in northeastern Mexico. PLoS One. 2022; 17(3 March):1–19. doi: https://doi.org/10.1371/journal.pone.0264273.
  24. 24. Vielot NA, Toval-Ruíz CE, Weber RP, Becker-Dreps S, Alemán Rivera T de J. Rectovaginal group B Streptococcus colonization among pregnant women in Nicaragua: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2021; 34(15):2418–26. doi: https://doi.org/10.1080/14767058.2019.1667324.
  25. 25. Crespo M del P, Henao Giraldo EA, Herrera, Helena Maria, Espitia CLM. Colonización por Streptococcus agalactiae en mujeres gestantes de los centros de atención de la ESE Norte en Cali. Ciencia & Salud. 2012; 1(2):23–31. doi: https://repositorio.usc.edu.co/handle/20.500.12421/812
  26. 26. Meza YBP, Ruiz GEG. Efficacy of a molecular test in the diagnosis of Streptococcus agalactiae in pregnant patients from the city of santa marta (Colombia). Salud Uninorte. 2020; 36(2):425–35. doi: https://doi.org/10.14482/sun.36.2.618.2.
  27. 27. Campo CH, Martínez MF, Otero JC, Rincón G. Prevalencia de colonización vaginorrectal por Streptococcus agalactiae y su perfil de sensibilidad en mujeres embarazadas atendidas en un hospital de tercer nivel. Biomedica. 2019; 39(4):689–98. doi: https://doi.org/10.7705/biomedica.4514.
  28. 28. Amaya-pino JP, Bello-trujillo A, Mendivil-ciodaro C, Correa-jiménez Ó, Reyes-ramos N. Prevalencia de colonización vaginal y rectal por Streptococcus agalactiae en gestantes con trabajo de parto pretérmino. Revista Ciencias Biomédicas. 2013; 4(1): 20-30. doi: https://doi.org/10.32997/rcb-2013-2747
  29. 29. Ceballos CA, Loaiza N, Romero J, Ospina M, Vásquez EM. Caracterización de las gestantes tamizadas para Streptococcus agalactiae y su relación con sepsis neonatal temprana, en la Clínica del Prado de Medellín (Colombia), año 2010. Infectio. 2014; 18(2):66–71. doi: https://doi.org/10.1016/j.infect.2013.12.002.
  30. 30. Vornhagen J, Adams Waldorf KM, Rajagopal L. Perinatal Group B streptococcal infections: Virulence factors, immunity, and prevention strategies. Trends Microbiol. 2017; 25(11):919–31. doi: https://doi.org/10.1016/j.tim.2017.05.013.
  31. 31. Lu J, Moore RE, Spicer SK, Doster RS, Guevara MA, Francis JD, et al. Streptococcus agalactiae npx Is Required for Survival in Human Placental Macrophages and Full Virulence in a Model of Ascending Vaginal Infection during Pregnancy. mBio. 2022; 13(6). doi: https://doi.org/10.1128/mbio.02870-22.
  32. 32. Allard MJ, Brochu ME, Bergeron JD, Segura M, Sébire G. Causal role of group B Streptococcus-induced acute chorioamnionitis in intrauterine growth retardation and cerebral palsy-like impairments. J Dev Orig Health Dis. 2019; 10(5):595–602. doi: https://doi.org/10.1017/S2040174418001083.
  33. 33. Fernández AA, Peraza GT, Hernández DM, Alegría AMO, Simón RF. Rectum/vaginal colonization by Streptococcus agalactiae in cuban pregnant women. Rev Cubana Med Trop. 2018; 70(3):27–37. Available in: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602014000300009&lng=es.
  34. 34. Monari F, Gabrielli L, Gargano G, Annessi E, Ferrari F, Rivasi F, et al. Fetal bacterial infections in antepartum stillbirth: A case series. Early Hum Dev. 2013; 89(12):1049–54. doi: https://doi.org/10.1016/j.earlhumdev.2013.08.010.
  35. 35. Vasikasin V, Changpradub D. Clinical manifestations and prognostic factors for Streptococcus agalactiae bacteremia among nonpregnant adults in Thailand. J Infect Chemother. 2021; 27(7):967–71. doi: https://doi.org/10.1016/j.jiac.2021.02.010.
  36. 36. Crespo-Ortiz MDP, Castan&tild;eda-Ramirez CR, Recalde-Bolan&tild;os M, et al. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: A 17-year study. BMC Infect Dis; 14. Epub ahead of print 2014. Doi: 10.1186/1471-2334-14-428.
  37. 37. Rosa-Fraile M, Spellerberg B. Reliable detection of Group B Streptococcus in the clinical laboratory. J Clin Microbiol. 2017; 55(9):2590–8. doi: https://doi.org/10.1128/JCM.00582-17.
  38. 38. Pena JMS, Lannes-Costa PS, Nagao PE. Vaccines for Streptococcus agalactiae: current status and future perspectives. Front Immunol. 2024; 15(June):1–7. doi: https://doi.org/10.3389/fimmu.2024.1430901.
  39. 39. Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. Maternal colonization with Group B Streptococcus and serotype distribution worldwide: Systematic review and meta-analyses. Clin Infect Dis. 2017; 65(Suppl 2): S100–11. doi: https://doi.org/10.1093/cid/cix658.
  40. 40. Russell NJ, Seale AC, Bianchi-Jassir F, Kohli-Lynch M, Tann CJ, Hall J, et al. Estimates of the burden of Group B Streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017; 65(Suppl 2):S200–19. doi: https://doi.org/10.1093/cid/cix664.
  41. 41. Almeida A, Rosinski-chupin I, Plainvert C. Parallel evolution of Group B Streptococcus hypervirulent clonal complex 17 unveils new pathoadaptive Mutations. 2017; 2(5):1–15. doi: https://doi.org/10.1128/msystems.00074-17
  42. 42. Plainvert C, El Alaoui F, Tazi A, Joubrel C, Anselem O, Ballon M, et al. Intrapartum group B Streptococcus screening in the labor ward by Xpert® GBS real-time PCR. Eur J Clin Microbiol Infect Dis. 2018; 37(2):265–70. doi: https://doi.org/10.1016/j.tim.2017.05.013.
  43. 43. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues. Pediatrics. 2011; 127(5):817–26. doi: https://doi.org/10.1542/peds.2010-2217.
  44. 44. Jiang Y, Zhou J, Li Z. To Evaluate Impact on detection rate of Streptococcus agalactiae in the third trimester of pregnancy. Research Square. 2023; 1–11. doi: https://doi.org/10.21203/rs.3.rs-2627065/v1.
  45. 45. Couturier BA, Weight T, Elmer H, Schlaberg R. Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates. J Clin Microbiol. 2014; 52(9):3429–32. doi: https://doi.org/10.1128/JCM.01081-14.
  46. 46. Gendrin C, Vornhagen J, Armistead B, Singh P, Whidbey C, Merillat S, et al. A nonhemolytic Group B Streptococcus strain exhibits hypervirulence. J. Infect. Dis. 2018; 217(6):983–7. doi: https://doi.org/10.1093/infdis/jix646.
  47. 47. Sroka-Oleksiak A, Pabian W, Sobońska J, Drożdż K, Bogiel T, Brzychczy-Włoch M. Do NAAT-Based methods increase the diagnostic sensitivity of Streptococcus agalactiae carriage detection in pregnant women? Diagnostics. 2023; 13(5). doi: https://doi.org/10.3390/diagnostics13050863.
  48. 48. Zhu Y, Lin XZ. Updates in prevention policies of early-onset group B streptococcal infection in newborns. Pediatr Neonatol. 2021; 62(5):465–75. doi: https://doi.org/10.1016/j.pedneo.2021.05.007.
  49. 49. Stoll BJ, Puopolo KM, Hansen NI, Sánchez PJ, Bell EF, Carlo WA, et al. Early-Onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 2020; 174(7). doi:10.1001/jamapediatrics.2020.0593.
  50. 50. Thwe PM, Faron ML, Pride DT, Cruz A, Gerstbrein D, Nahmod KA, et al. Multicenter evaluation of the Cepheid Xpert GBS LB XC Test. J Clin Microbiol. 2022; 60(12):7–12. doi: https://doi.org/10.1128/jcm.01356-22.
  51. 51. Mousavi SM, Hosseini SM, Mashouf RY, Arabestani MR. Identification of group B Streptococci using 16S rRNA, cfb, scpB, and atr genes in pregnant women by PCR. Acta Med Iran. 2016; 54(12):765–70. Available in https://pubmed.ncbi.nlm.nih.gov/28120587/
  52. 52. Escobar DF, Diaz-Dinamarca DA, Hernández CF, Soto DA, Manzo RA, Alarcón PI, et al. Development and analytical validation of real-time PCR for the detection of Streptococcus agalactiae in pregnant women. BMC Pregnancy Childbirth. 2020; 20(1):1–10. doi: https://doi.org/10.1186/s12884-020-03038-z.
  53. 53. Mashouf RY, Mousavi SM, Rabiee S, Alikhani MY, Arabestani MR. Direct identification of Streptococcus agalactiae in vaginal colonization in pregnant women using polymerase chain reaction. Journal of Comprehensive Pediatrics. 2014; 5(4):0–5. doi: https://doi.org/10.17795/compreped-23339.
  54. 54. Ferreira MB, de-Paris F, Paiva RM, Nunes L de S. Assessment of conventional PCR and real-time PCR compared to the gold standard method for screening Streptococcus agalactiae in pregnant women. Braz J Infect Dis. 2018; 22(6):449–54. doi: https://doi.org/10.1016/j.bjid.2018.09.005
  55. 55. Otaguiri ES, Morguette AEB, Morey AT, Tavares ER, Kerbauy G, de Almeida Torres RSL, et al. Development of a melting-curve based multiplex real-time PCR assay for simultaneous detection of Streptococcus agalactiae and genes encoding resistance to macrolides and lincosamides. BMC Pregnancy Childbirth. 2018; 18(1):1–12. doi: https://doi.org/10.1186/s12884-018-1774-5.
  56. 56. Vieira LL, Perez A V., Machado MM, Kayser ML, Vettori D V., Alegretti AP, et al. Group B Streptococcus detection in pregnant women: Comparison of qPCR assay, culture, and the Xpert GBS rapid test. BMC Pregnancy Childbirth. 2019; 19(1):1–8. doi: https://doi.org/10.1186/s12884-019-2681-0.
  57. 57. Zietek M, Jaroszewicz-Trzaska J, Szczuko M, Mantiuk R, Celewicz Z. Intrapartum pcr assay is a fast and efficient screening method for group b Streptococcus detection in pregnancy. Ginekol Pol. 2020; 91(9):549–53. doi: https://doi.org/10.5603/GP.2020.0088.
  58. 58. Zeng YF, Chen CM, Li XY, Chen JJ, Wang YG, Ouyang S, et al. Development of a droplet digital PCR method for detection of Streptococcus agalactiae. BMC Microbiol. 2020; 20:179. doi: https://doi.org/10.1186/s12866-020-01857-w.
  59. 59. Han MY, Xie C, Huang QQ, Wu QH, Deng QY, Xie TA, et al. Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae. Ann Clin Microbiol Antimicrob. 2021; 20(1):1–11. doi: https://doi.org/10.1186/s12941-021-00461-8.
  60. 60. Bogiel T, Depka D, Zalas-Więcek P, Rzepka M, Kruszyńska E, Gospodarek-Komkowska E. Application of the appropriate molecular biology-based method significantly increases the sensitivity of group B Streptococcus detection results. J Hosp Infect. 2021; 112:21–6. doi: https://doi.org/10.1016/j.jhin.2021.03.008.
  61. 61. Bogiel T, Ziółkowski S, Domian A, Dobrzyńska Z. An application of real-time PCR and CDC protocol may significantly reduce the incidence of Streptococcus agalactiae infections among neonates. Pathogens. 2022; 11(9). doi: https://doi.org/10.3390/pathogens11091064.
  62. 62. Peris MP, Martín-Saco G, Alonso-Ezcurra H, Escolar-Miñana C, Rezusta A, Acero R, et al. Retrospective study for the clinical evaluation of a real-time PCR assay with lyophilized and ready-to-use reagents for Streptococcus agalactiae detection in prenatal screening specimens. Diagnostics. 2022; 12(9). doi: https://doi.org/10.3390/diagnostics12092189.
  63. 63. Daniels J, Dixon EF, Gill A, Bishop J, D’amico M, Ahmed K, et al. A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT. Health Technol Assess (Rockv). 2022; 26(12): vii–76. doi: https://doi.org/10.3310/BICF1187.
  64. 64. Chen XJ, Wan TW, Chao QT, Teng LJ, Lee T fen, Huang YT, et al. Applicability of an in-house extraction protocol in a Bruker Biotyper matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of Streptococcus agalactiae from broth-enriched vaginal/rectal swab specimens. J. Microbiol. Immunol. Infect. 2023; 56(4):815–21. doi: https://doi.org/10.1016/j.jmii.2023.05.003.
  65. 65. Koliwer-Brandl H, Nil A, Birri J, Sachs M, Zimmermann R, Zbinden R, et al. Evaluation of two rapid commercial assays for detection of Streptococcus agalactiae from vaginal samples. Acta Obstet Gynecol Scand. 2023; 102(4):450–6. doi: https://doi.org/10.1111/aogs.14519.
  66. 66. McKenna JP, Cox C, Fairley DJ, Burke R, Shields MD, Watt A, et al. Loop-mediated isothermal amplification assay for rapid detection of Streptococcus agalactiae (group B Streptococcus) in vaginal swabs - a proof of concept study. J Med Microbiol. 2017; 66(3):294–300. doi: https://doi.org/10.1099/jmm.0.000437.
  67. 67. Guo XG, Zhuang YR, Wen JZ, Xie TA, Liu YL, Zhu GD, et al. Evaluation of the real-time fluorescence loop-mediated isothermal amplification assay for the detection of Streptococcus agalactiae. Biosci Rep. 2019; 39. doi: https://doi.org/ 10.1042/BSR20190383.
  68. 68. Pu W, Wang Y, Yang N, Guo G, Li H, Li Q, et al. Investigation of Streptococcus agalactiae using pcsB-based LAMP in milk, tilapia and vaginal swabs in Haikou, China. J Appl Microbiol. 2020; 128(3):784–93. doi: https://doi.org /10.1111/jam.14501
  69. 69. Xu X, Jia Y, Li R, Wen Y, Liang Y, Lao G, et al. Rapid and simultaneous detection of multiple pathogens in the lower reproductive tract during pregnancy based on loop-mediated isothermal amplification-microfluidic chip. BMC Microbiol. 2022; 22(1):1–16. doi: https://doi.org/10.1186/s12866-022-02657-0.
  70. 70. van der Linden M, Jaschek M, Junker J, Levina N, Weidenhaupt B. Evaluation of the ‘HG Group B Streptococcus’ loop-mediated isothermal amplification assay for accurate identification of Streptococcus agalactiae. J Med Microbiol. 2022; 71(12):1–4. doi: https://doi.org/10.1099/jmm.0.001609.
  71. 71. Sung JH, Cha HH, Lee NY, Lee WK, Choi Y, Han HS, et al. Diagnostic accuracy of loop-mediated isothermal amplification assay for Group B Streptococcus detection in recto-vaginal swab: Comparison with polymerase chain reaction test and conventional culture. Diagnostics. 2022; 12(7). doi: https://doi.org/10.3390/diagnostics12071569.
  72. 72. Lemaire C, Cheminet M, Duployez C, Artus M, Ballaa Y, Devos L, et al. A LAMP-based assay for the molecular detection of group B Streptococcus. Eur. J. Clin. Microbiol. Infect. Dis. 2023; 42(10):1245–50. doi: https://doi.org/10.1007/s10096-023-04656-z.
  73. 73. Chen J, Wang Y, Liu X, Chen G, Chen X, Chen J, et al. Development of propidium monoazide–recombinase polymerase amplification (PMA-RPA) assay for rapid detection of Streptococcus pyogenes and Streptococcus agalactiae. Mol Cell Probes. 2018; 41:32–8. doi: https://doi.org/10.1016/j.mcp.2018.08.007
  74. 74. Hu S, Zhong H, Huang W, Zhan W, Yang X, Tang B, et al. Rapid and visual detection of Group B Streptococcus using recombinase polymerase amplification combined with lateral flow strips. Diagn Microbiol Infect Dis. 2019; 93(1):9–13. doi: https://doi.org/10.1016/j.diagmicrobio.2018.07.011.
  75. 75. Yu D, Liang B, Xu H, Chen L, Ye Z, Wu Z, et al. CRISPR/Cas12a-based assay for the rapid and high-sensitivity detection of Streptococcus agalactiae colonization in pregnant women with premature rupture of membrane. Ann Clin Microbiol Antimicrob [Internet]. 2023; 22(1):1–11. doi: https://doi.org/10.1186/s12941-023-00558-2
  76. 76. To KN, Cornwell E, Daniel R, Goonesekera S, Jauneikaite E, Chalker V, et al. Evaluation of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) for the Identification of Group B Streptococcus. BMC Res Notes. 2019; 12(1):10–5. doi: https://doi.org/10.1186/s13104-019-4119-1.
  77. 77. Tanno D, Saito K, Ohashi K, Toyokawa M, Yamadera Y, Shimura H. Matrix-assisted laser desorption ionization – Time-of-flight mass spectrometry with Time-of-Flight peak analysis for rapid and accure detection of Group B Streptococcus in pregnant women. Microbiol Spectr. 2022; 45(March):1–10. doi: https://doi.org/ 10.1128/spectrum.01732-21.
  78. 78. Emonet S, Schrenzel J, Martinez De Tejada B. Molecular-based screening for perinatal group B streptococcal infection: Implications for prevention and therapy. Mol Diagn Ther. 2013; 17(6):355–61. doi:10.1007/s40291-013-0047-2.
  79. 79. Andreasen T, Møller JK, Khalil MR. Comparison of BD MAX GBS and GenomEra GBS assays for rapid intrapartum PCR detection of vaginal carriage of group B streptococci. PLoS One. 2019; 14(4):1–10. doi: https://doi.org/10.1371/journal.pone.0215314.
  80. 80. Schörner, M. A., May Feuershuette, O. H., Scheffer, M. C., Senna, S. G., and Bazzo, M. L. Detection of Group B Streptococcus agalactiae from anorectal and vaginal screening tests. Clin Microbial, 2014; 3(169):1–5. doi: http://dx.doi.org/10.4172/2327-5073.1000169
  81. 81. Breeding KM, Ragipani B, Lee KUD, Malik M, Randis TM, Ratner AJ. Real-time PCR-based serotyping of Streptococcus agalactiae. Sci Rep. 2016; 6:1–6. doi: https://doi.org/10.1038/srep38523.
  82. 82. Furfaro LL, Chang BJ, Payne MS. Perinatal Streptococcus agalactiae epidemiology and surveillance targets. Clin Microbiol Rev 2018; 31(4): e00049-18. doi: https://doi.org/10.1128/CMR.00049-18.
  83. 83. Alsheim E, Thet NT, Laabei M, Jenkins ATA. Development and early testing of a simple, low cost, fast sensor for maternal and neonatal group B Streptococcus. Biosens Bioelectron. 2024; 247(October 2023):115923. doi: https://doi.org/10.1016/j.bios.2023.115923.

Información

Palabras clave

Código QR

Sistema OJS 3.4.0.10 - Metabiblioteca |